VBS Fellows Foray 2021: Case-Based Examples and Real-World Treatment Strategies - On-demand Webinar

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

VBS Moderators:

Panelists:

Fellows: 

DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity. The following faculty/staff members have the following financial relationships with commercial interests:

Moderators:

Anton Orlin, MD, has no financial relationships with commercial interests.

D. Wilkin Parke III, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Royalties: Vortex Surgical.

Aleksandra V. Rachitskaya, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Carl Zeiss Meditec, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Genentech, and Novartis.

Camila Ventura, MD, PhD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: NICHD/NIH. Speaker’s Bureau: Novartis.

Panelists:

S.K. Steven Houston III, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, and Optos. Stock/Shareholder: Healtheia.
Jennifer I. Lim, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Cognition, Eyenuk, Genentech, Iveric, Novartis, and Regeneron Pharmaceuticals. Data Monitoring Committee: Aura Bioscience, Ophthea, Quark, and Santen. Grant/Research Support: Allergan, Chengdu Pharma, Genentech, Graybug, Regeneron Pharmaceuticals, and Stealth.
André Maia, MD, PhD has no financial relationships with commercial interests.

Fellows:
Saud ALJohani, MD, Natasha Cruz, MD, Luis C. Escaf, MD, Tahsin Khundkar, MD, Diana M. Laura, MD, Huy Nguyen, MD, Hassan N. Tausif, MD, Adam Weiner, MD have no financial relationships with commercial interests.

Editorial Support Disclosures
The Evolve staff and planners have no financial relationships with commercial interests.  Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.